MarketInOut Stock Screener Log In | Sign Up
 

Aquestive Therapeutics Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
Aquestive Therapeutics Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization503.93 mln
Float119 mln
Earnings Date11/09/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.95
Highly reliable

Relative Strength

16 / 100
Significantly lagging

Pre-Tax Margin

-145%
Severely loss-making

ROE

244
Extraordinary

Altman Z-Score

-3.41
Deeply distressed

Business Description

Aquestive Therapeutics is a US-based pharmaceutical company that develops and sells medicines in film-based formats, making treatments easier to take for patients with conditions such as epilepsy, opioid dependence, and ADHD. The company has several products already on the market, including treatments for seizures and allergic reactions, alongside a growing pipeline of new therapies currently in clinical trials. Founded in 2004 and based in Warren, New Jersey, Aquestive also licenses its proprietary film delivery technology to other drug makers targeting disorders of the central nervous system.

Key Fundamentals

EPS-0.66
ROE244
RPS0.45
ROIC-197
ROA-56.47
Interest Cover-3.23
EBITDA, mln-61.38
EV / EBITDA-10.26
EV / EBIT-10.17
Revenue, mln54.09
EV / Revenue11.64

Quote Details

Last 4.00
Change -0.13 (-3.15%)
Open 4.08
Volume 1,699,913
Turnover 6,799,652
Average Volume 2,155,060

Financial Ratios

Pre-Tax Profit Margin-145
Current Ratio7.19
Price / Sales10.27

Financial Strength

Altman Z-Score-3.41
Piotroski F-Score 5 / 9
Beneish M-Score-3.95
Short Ratio12.69
Short % of Float23.98

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 5.82% 90 / 100   
1 Month -17.01% 21 / 100   
2 Months 1.27% 68 / 100   
6 Months -1.96% 48 / 100   
1 Year -41.52% 21 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog